Top Pharma Listing Pages Archive - PMLiVE
This handy resource ranks the top companies in the pharmaceutical industry by their global sales, as well as by revenues in the US, Europe and Japan. The Top Pharma List also features profile pages for each pharma company and additional rankings …
Pharmaceutical industry news, articles, jobs, reports, advice and ...
Merck shares positive results for Keytruda in phase 3 bladder cancer study. About 83,000 people in the US will be diagnosed with bladder cancer in 2024
FDA approves Pfizer/BioNTech and Moderna’s updated COVID-19 …
2023年9月12日 · The US Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna to more closely target currently circulating variants.
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, advice ... ... News
Pharmaceutical industry news, articles, jobs, reports, advice and ...
Find pharmaceutical jobs, news, career advice and articles on PMLive, the leading resource for the pharmaceutical and healthcare industry.
Research Archives - PMLiVE
The healthcare provider’s previous donation is supporting research into early melanoma detection. Read More
Sanofi/Regeneron’s Dupixent shows promise in chronic obstructive ...
2023年5月24日 · Sanofi and Regeneron’s Dupixent (dupilumab) was associated with significant improvements in uncontrolled chronic obstructive pulmonary disease (COPD), according to positive phase 3 results presented at the 2023 American Thoracic Society International Conference. The results from the BOREAS trial, which met the primary and all secondary ...
Pharmaceutical industry news, articles, jobs, reports, advice and ...
Roche and Exelis/Ipsen's drug combination shows promise in phase 3 prostate cancer study. Around 299,000 new cases of prostate cancer will be diagnosed in the US in 2024
Healthcare - PMLiVE
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site.
Chinese biotech’s global ambitions - PMLiVE
2018年10月8日 · BeiGene is one of a new wave of Chinese biopharma companies to list on the Hong Kong stock exchange, raising a huge $903m when it went public in August.. However while there are doubts about the robustness of some of the ‘pre-revenue’ biotechs now raising money or planning to raise money through Hong Kong IPOs, BeiGene looks like a potential contender for the future – not just in China ...